Literature DB >> 17423235

Heartbase tumor and pericardial effusion in a dog.

R Difruscia, M A Perrone, N H Bonneau, L Breton.   

Abstract

Pericardial effusion and congestive heart failure occurred in a ten-year-old male Bouvier des Flandres dog. Signs included weakness, exercise intolerance and ascites. Echocardiography identified a heart base mass as a possible cause of the pericardial effusion. A large quantity (650 mL) of bloody fluid was removed by pericardiocentesis and was characterized at cytology as a nonseptic sanguineous exudate. There was no cytological evidence of neoplasia in the effusate. Pericardiocentesis caused dramatic clinical improvement and resolution of the signs of congestive heart failure. Surgical excision was attempted but the mass could not be resected since it invaded the entire dorsal wall of the right atrium as well as part of the aortic root. The cellular origin of the heartbase tumor could not be determined.

Entities:  

Year:  1989        PMID: 17423235      PMCID: PMC1681030     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  5 in total

1.  Electrical alternans associated with pericardial effusion in the dog.

Authors:  J D Bonagura
Journal:  J Am Vet Med Assoc       Date:  1981-03-15       Impact factor: 1.936

2.  Cardiac hemangiosarcoma in the dog: a review of 38 cases.

Authors:  M Aronsohn
Journal:  J Am Vet Med Assoc       Date:  1985-11-01       Impact factor: 1.936

3.  Diagnostic value of pericardial fluid analysis in the dog.

Authors:  D Sisson; W P Thomas; W W Ruehl; J G Zinkl
Journal:  J Am Vet Med Assoc       Date:  1984-01-01       Impact factor: 1.936

4.  Pericardial effusion and electrical alternans: echocardiographic assessment.

Authors:  J A Sbarbaro; H L Brooks
Journal:  Postgrad Med       Date:  1978-03       Impact factor: 3.840

5.  Idiopathic hemorrhagic pericardial effusion in eight dogs.

Authors:  R J Berg; W E Wingfield; P J Hoopes
Journal:  J Am Vet Med Assoc       Date:  1984-11-01       Impact factor: 1.936

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.